E
Everest Medicines
Developing and commercialising novel transformative pharmaceutical therapies
About Everest Medicines
Everest Medicines was founded with a vision to address the critical need for innovative medicines in Asia. The company was co-founded by Wei Fu, who brought a wealth of experience from his previous roles in the pharmaceutical industry. Everest Medicines focuses on licensing, developing, and commercializing transformative pharmaceutical products that address critical unmet medical needs.
Read full description
The company has strategically partnered with global biopharmaceutical companies to bring cutting-edge therapies to the Asian market. This approach has allowed Everest Medicines to build a robust pipeline of promising drug candidates across oncology, immunology, cardio-renal, and infectious diseases.
A significant milestone in Everest Medicines' journey was its successful IPO on the Hong Kong Stock Exchange in October 2020. This event marked a new chapter for the company, providing the necessary capital to accelerate its development programs and expand its commercial capabilities.
Everest Medicines continues to leverage its strong partnerships and innovative pipeline to make a meaningful impact on patients' lives in Asia. The company's commitment to addressing unmet medical needs remains at the core of its mission, driving its growth and success in the biopharmaceutical industry.
At a glance
- Founded
- 2017
- Headquarters
- New York City, United States
- Listing
- IPO 2020
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
CBC Group
Cormorant Asset Management
HBM Healthcare Investments
Series B and later3 investors entered at this stage
Janchor Partners
Hillhouse Capital
RA Capital Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
10 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Everest Medicines on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Everest Medicines on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.